{"id":"W2886957118","doi":"10.1016/j.dadm.2018.06.007","title":"Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers","year":2018,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health; Genentech; IXICO; H. Lundbeck A/S; Servier; Eisai; Northern California Institute for Research and Education; Pfizer; Novartis Pharmaceuticals Corporation; University of Southern California; Biogen; Meso Scale Diagnostics; U.S. Department of Defense; Alzheimer's Disease Neuroimaging Initiative; Eli Lilly and Company; Bristol-Myers Squibb; National Institute on Aging; Alzheimer's Association; Canadian Institutes of Health Research; National Science Foundation","keywords":"Neuroimaging; Disease; Alzheimer's Disease Neuroimaging Initiative; Biomarker; Medicine; Receiver operating characteristic; Neurodegeneration; Logistic regression; Clinical trial; Oncology; Machine learning; Alzheimer's disease; Artificial intelligence; Psychology; Internal medicine; Computer science; Biology; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006156542,0.0004665222,0.0004356945,0.001391795,0.0002876058,0.001017372,0.0004963914,0.0005461425,0.0008323836],"category_scores_gemma":[0.01181797,0.0002283869,0.000711405,0.0007694931,0.0003634897,0.0009527458,0.0007352154,0.0007061677,0.0001503009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005663964,"about_ca_system_score_gemma":0.000584495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007108188,"about_ca_topic_score_gemma":0.006958403,"domain_scores_codex":[0.9991773,0.0004368444,0.00005987534,0.0002177979,0.00004379592,0.00006434607],"domain_scores_gemma":[0.9931846,0.004136424,0.001410139,0.0006925086,0.0003411502,0.0002352968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003443628,0.0001165427,0.9578013,0.00002816282,0.0003009207,0.00008051868,0.0001623565,0.02239581,0.001065338,0.0005676733,0.0004114204,0.01672558],"study_design_scores_gemma":[0.00005176194,0.0003752069,0.544144,0.00006360242,0.0002065494,0.0002624591,0.0003491401,0.4407936,0.001418782,0.01161444,0.0006648231,0.00005576192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837707,0.0002451849,0.01467406,0.0002667014,0.000006191757,0.00001955371,0.0007469354,0.0000501216,0.0002204602],"genre_scores_gemma":[0.9971918,0.00004551868,0.002215603,0.00002304877,0.00000644134,0.00001427876,0.0004353253,0.000003234906,0.00006479833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007108188,"threshold_uncertainty_score":0.03255934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.106944356319326,"score_gpt":0.4485654580687972,"score_spread":0.3416211017494712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}